Sai Life Sciences Opens New Veterinary API Facility in Bidar

Sai Life Sciences, a leading contract research, development, and manufacturing organization (CRDMO), has inaugurated Unit VI, its first facility dedicated exclusively to veterinary active pharmaceutical ingredients (APIs), in Bidar, Karnataka.

Strategically located adjacent to its flagship Unit IV API manufacturing site, the new unit marks a significant step in the company’s expansion into animal healthcare. Designed to meet the rising global demand for veterinary pharmaceuticals, the facility upholds the highest standards in safety, sustainability, and regulatory compliance.

“This investment strengthens our ability to meet the growing global demand for high-quality veterinary pharmaceuticals while ensuring the highest standards of innovation, efficiency, and sustainability,” said Krishna Kanumuri, CEO & MD, Sai Life Sciences.

The new facility supports the company’s broader strategy to expand into niche, high-value pharmaceutical segments and provide innovator partners with reliable, scalable, and future-ready manufacturing solutions aimed at advancing animal health and well-being.

News by Rahul Yelligetti.